{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:59:03Z","timestamp":1768633143255,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ejso.2012.02.187","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T17:25:08Z","timestamp":1332869108000},"page":"637-642","source":"Crossref","is-referenced-by-count":14,"title":["External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder"],"prefix":"10.1016","volume":"38","author":[{"given":"P.","family":"Nuhn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-M.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Buchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brookman-May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bolenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"H\u00f6fner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Tilki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Roigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zacharias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Trojan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"W\u00fclfing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Haferkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gilfrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.F.","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejso.2012.02.187_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ejso.2012.02.187_bib2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","volume":"59","author":"Stenzl","year":"2011","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ejso.2012.02.187_bib3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.eururo.2011.01.014","article-title":"Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy","volume":"59","author":"Feifer","year":"2011","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ejso.2012.02.187_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.eururo.2011.01.030","article-title":"Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy","volume":"59","author":"May","year":"2011","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ejso.2012.02.187_bib5","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-010-1538-6","article-title":"Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy","volume":"18","author":"May","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2012.02.187_bib6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.juro.2010.09.110","article-title":"Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer","volume":"185","author":"Sonpavde","year":"2011","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ejso.2012.02.187_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.eururo.2008.10.016","article-title":"Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer","volume":"55","author":"Calabro","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ejso.2012.02.187_bib8","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","article-title":"Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"issue":"6)","key":"10.1016\/j.ejso.2012.02.187_bib9","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.juro.2010.02.021","article-title":"Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4400 patients","volume":"183","author":"Novara","year":"2010","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ejso.2012.02.187_bib10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2009.03.052","article-title":"Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications","volume":"57","author":"May","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ejso.2012.02.187_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"7","key":"10.1016\/j.ejso.2012.02.187_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","article-title":"Surrogate end points in clinical trials: are we being misled?","volume":"125","author":"Fleming","year":"1996","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ejso.2012.02.187_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PPO.0b013e3181bdc2e0","article-title":"Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials","volume":"15","author":"Driscoll","year":"2009","journal-title":"Cancer J"},{"issue":"6 Pt 1","key":"10.1016\/j.ejso.2012.02.187_bib14","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J Urol"},{"issue":"29","key":"10.1016\/j.ejso.2012.02.187_bib15","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1200\/JCO.2006.10.4323","article-title":"End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group","volume":"25","author":"Sargent","year":"2007","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.ejso.2012.02.187_bib16","doi-asserted-by":"crossref","first-page":"8664","DOI":"10.1200\/JCO.2005.01.6071","article-title":"Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18\u00a0randomized trials","volume":"23","author":"Sargent","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.ejso.2012.02.187_bib17","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1158\/0008-5472.CAN-10-1202","article-title":"MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer","volume":"70","author":"Choudhury","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2012.02.187_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/epi.10.71","article-title":"Global epigenetic profiling in bladder cancer","volume":"3","author":"Dudziec","year":"2011","journal-title":"Epigenomics"},{"issue":"5","key":"10.1016\/j.ejso.2012.02.187_bib19","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.juro.2010.01.018","article-title":"Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers","volume":"183","author":"Shariat","year":"2010","journal-title":"J Urol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798312002405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798312002405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T22:24:39Z","timestamp":1543098279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798312002405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0748798312002405"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2012.02.187","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}